Select your Market

Global
Africa
Algeria
Angola
Benin
Botswana
Burkina Faso
Burundi
Cameroon
Cape Verde
Central African Republic
Chad
Comoros
Congo
Congo Democratic Republic
Djibouti
Egypt
Equatorial Guinea
Eritrea
Ethiopia
Gabon
Gambia
Ghana
Guinea
Guinea-Bissau
Ivory Coast
Kenya
Lesotho
Liberia
Libya
Madagascar
Malawi
Mauritania
Mauritius
Morocco
Mozambique
Namibia
Niger
Nigeria
Reunion Islands
Rwanda
Saint Helena
São Tomé and Príncipe
Senegal
Seychelles
Sierra Leone
Somalia
South Africa
Sudan
Swaziland
Tanzania
Togo
Tunisia
Uganda
Zambia
Zimbabwe
Asia
Bahrain
Bangladesh
China, mainland
India
Indonesia
Iran
Iraq
Israel
Japan
Jordan
Kuwait
Lebanon
Malaysia
Oman
Palestine
Philippines
Qatar
Saudi Arabia
Singapore
South Korea
Syria
Taiwan
Thailand
Turkey
United Arab Emirates
Vietnam
Yemen
Europe
Albania
Austria
Baltic Region
Belarus
Belgium
Bulgaria
Croatia
Cyprus
Czech Republic
Denmark
Estonia
Finland
France
Germany
Greece
Hungary
Ireland
Italy
Latvia
Lithuania
Luxembourg
Netherlands
North Macedonia
Norway
Poland
Portugal
Romania
Russian Federation
Serbia
Slovakia
Slovenia
Spain
Sweden
Switzerland
Türkiye
Ukraine
United Kingdom
Latin America
Argentina
Aruba
Bahamas
Barbados
Belize
Bolivia
Brazil
Central America
Chile
Colombia
Costa Rica
Cuba
Curacao-NL Antillen
Ecuador
El Salvador
Guatemala
Haiti
Honduras
Jamaica
Mexico
Nicaragua
Panama
Paraguay
Perú
República Dominicana
Trinidad and Tobago
Uruguay
Venezuela
North America
Canada
United States of America
Oceania
Australia
New Zealand
Global
CAREERS

First Quarter: Strong Start into Fiscal 2022

Our growth story continues to materialize. Group sales increased organically by 7.8% to € 5.2 billion compared with the year-earlier quarter.

Key facts and Forecast

Results of Q1 2022

  • Group sales increase by 12.2% to € 5.2 billion; EBITDA pre up 7.8% to € 1.6 billion; EBITDA pre margin 31.3%
  • Growth story continues to materialize
  • High margins in all three businesses despite challenging economic headwinds and increasing global uncertainty

Forecast for fiscal 2022

  • Company specifies forecast for net sales, EBITDA pre and earnings per share pre
  • Net sales between € 21.6 billion and € 22.8 billion; EBITDA pre in a range between € 6.6 billion and € 7.1 billion; earnings per share pre between € 9.60 and € 10.50

Overview: Business performance in Q1 2022

       

Group net sales:

€ 5.2 bn.

+12.2%

(organic: +7.8%)

EBITDA pre:

€ 1.6 bn.

+7.8%

(organic: +1.6%)

Life Science:

€ 2.4 bn.

+14.7%

(organic: +9.7%)

Healthcare:

€ 1.8 bn.

+9.5%

(organic: +6.5%)

Electronics:

€ 957 m.

+11.2%

(organic: +5.2%)

Belén Garijo - Chair of the Executive Board and CEO of Merck KGaA, Darmstadt, Germany

We have made a promising start to 2022, with our Big 3 generating strong growth and attractive margins.

Belén Garijo

Chair of the Executive Board and CEO of Merck KGaA, Darmstadt, Germany

  • Quarterly Statement Q1 2022 Brochure Quarterly Statement Q1 2022 Brochure

    Quarterly Statement Q1 2022

    Detailed information about our business in the first quarter of 2022.
    Download (PDF)

ADDITIONAL INFORMATION

Financial Report
 

Downloads for the Media

Additional Downloads

Annual Reports Archive

Find previous Annual Reports, Corporate Governance Reports & Statements in our archive.
Read more

Related News

View All News

  1. Press Releases

    Merck KGaA, Darmstadt, Germany, Delivers Strong First Quarter

    Merck KGaA, Darmstadt, Germany, achieved strong results in the first quarter of 2022. Net sales increased by 12.2% to € 5,198 million compared with the year-earlier quarter.

    2022/05/12

Gangolf Schrimpf

Media Relations

+49 151 1454 9591

Constantin Fest

Head of Investor Relations

+49 6151 72-5271

+49 6151 72 91-5271